Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont Pictures Definity Imaging Agent Launch Supported By User Training

This article was originally published in The Gray Sheet

Executive Summary

DuPont Pharmaceuticals plans to support an autumn launch of its Definity echocardiography ultrasound contrast agent with a user training program.

You may also be interested in...



Combo Product Excitement: Large Players On Look-Out For Early-Stage Deals

Heightened corporate interest in innovative drug-delivery technologies offers greater opportunities for small device firms to attract larger company investment, venture capitalists say

Combo Product Excitement: Large Players On Look-Out For Early-Stage Deals

Heightened corporate interest in innovative drug-delivery technologies offers greater opportunities for small device firms to attract larger company investment, venture capitalists say

Acusphere AI-700 Imaging Agent Phase III Protocols Expected By Early 2002

Acusphere plans to submit Phase III protocols for its ultrasound contrast agent AI-700 to FDA by early 2002.

UsernamePublicRestriction

Register

LL1134786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel